All News

Every patient with cancer deserves to be in a safe environment, so it is important to know the signs of an abusive caregiver.

Having multiple options for frontline treatment of CLL may be better than deciding on one standard, an expert says.

The combination of lirilumab Opdivo proved to be effective for a subet of patients with head and neck cancer, according to a recent study.

Journal writing can be your window to wellness.

Many breast cancer survivors use psychotropic and opioid medications, pointing to an unmet need for psychological care in this population.

Showing gratitude in spite of the changes that cancer brings.

A recent study outlined both the risks and benefits of sun exposure. Authors say that sensible sun exposure (without getting sun burn) may actually decrease a person's risk of getting melanoma.

The treatment landscape for chronic lymphocytic leukemia (CLL) is going to drastically change over the next decade or so, says Jose Leis, M.D.

Roman Perez-Soler, M.D. discusses the EGFR resistance in non-small cell lung cancer (NSCLC).

Learning to appreciate time after cancer.

In colorectal and other cancers, financial burden is worsened by expensive drugs, long-term treatment and sharing of insurance costs.

When it comes to bladder cancer, PD-1 and PD-L1 agents will become the new mainstay, says Jonathan E. Rosenberg, M.D.

Expert Howard I. Scher, M.D. discusses the future of liquid biopsy use for prostate cancer.

Kim writes about moving past a diagnosis and taking action.

Breast cancer and melanoma survivors shares thoughts to fight cancer fatigue from a book by Christiane Northrup, M.D.

There are many misconceptions about genetic testing in cancer, but the SGO crafted a new toolkit to help patients and providers navigate the field.

The FDA approved a Darzalex (daratumumab) triplet for the treatment of relapsed myeloma.

While Opdivo is currently the only immunotherapy agent approved for Hodgkin lymphoma, immunotherapy strategies are beginning to emerge in other indications in the field.

Linda T. Vahdat, M.D. discusses the findings of a recent phase 2 trial that may lead to the approval of a targeted therapy for triple-negative breast cancer.

Through music, Christian Hoff shares his message of hope for patients and survivors of cancer.

Long-term data from the phase 3 EF-14 study showed that Optune plus temozolomide had a survival benefit compared to temozolomide alone.

I was diagnosed in October and began chemotherapy at the beginning of November. The traditional month of food and family was one that I had always looked forward to.

Strides have been made in treating chemotherapy-induced nausea and vomiting (CINV), but there is still work that needs to be done.

Patients with breast cancer who had higher levels of vitamin D in their blood at diagnosis tended to have better outcomes, according to a recent study.

A brief interaction at the gym gives this metastatic breast cancer patient a reason to reflect on the hope we must nurture.

People from around the country, including actress and 16-year cancer survivor Fran Drescher , came to CURE's GBM Heroes event, honoring those who made an impact in the world of glioblastoma multiforme.

A promising treatment option is on the horizon for some patients with glioblastoma multiforme (GBM), says Martin van den Bent, M.D., Ph.D.